Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pathologic Complete Response × FOLFOXIRI protocol × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 10 Rectal Neoplasms 9 Colonic Neoplasms 4 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Liver Metastasis Colon Cancer 1 Carcinoma, Neuroendocrine 1

Interventions

Trastuzumab 4 Oxaliplatin 4 Fluorouracil 4 Cyclophosphamide 4 pembrolizumab 3 Radiotherapy 3 Paclitaxel 3 Endoscopy 3 Docetaxel 3 Cytarabine 3 Chemoradiotherapy 3 Carboplatin 3 Capecitabine 3 Surgical Procedures, Operative 2 Standard of Care 2 Observation 2 Metformin 2 Magnetic Resonance Imaging 2 Leucovorin 2 Irinotecan 2 Immunotherapy 2 Immune Checkpoint Inhibitors 2 Epirubicin 2 Drug Therapy 2 Doxorubicin 2 Cisplatin 2 Blood Specimen Collection 2 zanidatamab 1 venetoclax 1 veliparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07472868 2026-03-16

MEND-IT II

Catharina Ziekenhuis Eindhoven

Phase 3 Not yet recruiting

Pathologic Complete Response

Data powered by HemOnc (CC BY 4.0) Colophon ⚡